Grace Therapeutics, Inc.
GRCE
$4.44
-$0.01-0.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.67M | 16.86M | 20.01M | 22.13M | 11.06M |
| Total Receivables | 20.00K | 20.00K | 20.00K | 126.00K | 301.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 519.00K | 416.00K | 500.00K | 453.00K | 583.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 19.21M | 17.30M | 20.53M | 22.71M | 11.94M |
|
|
|||||
| Total Current Assets | 19.21M | 17.30M | 20.53M | 22.71M | 11.94M |
| Net Property, Plant & Equipment | 11.00K | 12.00K | 14.00K | 2.00K | 19.00K |
| Long-term Investments | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M |
| Goodwill | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M |
| Total Other Intangibles | 41.13M | 41.13M | 41.13M | 41.14M | 41.13M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 68.49M | 66.58M | 69.81M | 71.99M | 61.22M |
|
|
|||||
| Total Accounts Payable | 114.00K | 459.00K | 1.34M | 601.00K | 665.00K |
| Total Accrued Expenses | 1.17M | 786.00K | 976.00K | 1.33M | 1.31M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.28M | 1.25M | 2.32M | 1.93M | 1.97M |
|
|
|||||
| Total Current Liabilities | 1.28M | 1.25M | 2.32M | 1.93M | 1.97M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.31M | 2.51M | 3.94M | 3.45M | 7.11M |
| Total Liabilities | 3.60M | 3.76M | 6.26M | 5.38M | 9.09M |
|
|
|||||
| Common Stock & APIC | 298.23M | 293.84M | 293.64M | 293.34M | 279.50M |
| Retained Earnings | -227.30M | -224.99M | -224.05M | -220.69M | -221.32M |
| Treasury Stock & Other | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M |
| Total Common Equity | 64.89M | 62.82M | 63.55M | 66.61M | 52.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 64.89M | 62.82M | 63.55M | 66.61M | 52.14M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 64.89M | 62.82M | 63.55M | 66.61M | 52.14M |
|
|
|||||